Amelie Gubitz, Ph.D.

Job Title
Program Director
Amelie Gubitz
Division of Neuroscience
Cluster, Section, or Program
Neurodegeneration, Dementia, and Repeat Expansion Disorders
Areas of Interest

Amyotrophic Lateral Sclerosis (ALS), Accelerated Medicines Partnership® for ALS (AMP® ALS)

Contact Email

Dr. Amelie Gubitz serves as a Program Director for Amyotrophic Lateral Sclerosis (ALS) in the Division of Neuroscience at the National Institute of Neurological Disorders and Stroke. She also supports the Accelerating Medicines Partnership® for ALS (AMP® ALS). Dr. Gubitz earned a Ph.D. in pharmacology from the University of Cambridge, UK, and then completed a Wellcome Trust Fellowship at Harvard Medical School in circadian biology. She has also worked as a Senior Scientist in the target discovery group for neuropathic pain at Parke Davis, UK, and as a Research Assistant Professor at the University of Pennsylvania where she studied the molecular pathogenesis of spinal muscular atrophy.